NDC 68001-480

Irinotecan hydrochloide

Irinotecan Hydrochloide

Irinotecan hydrochloide is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Bluepoint Laboratories. The primary component is Irinotecan Hydrochloride.

Product ID68001-480_47f7ef14-1f7a-e924-3fc5-a692f7199967
NDC68001-480
Product TypeHuman Prescription Drug
Proprietary NameIrinotecan hydrochloide
Generic NameIrinotecan Hydrochloide
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2020-12-14
Marketing CategoryANDA / ANDA
Application NumberANDA212993
Labeler NameBluePoint Laboratories
Substance NameIRINOTECAN HYDROCHLORIDE
Active Ingredient Strength20 mg/mL
Pharm ClassesTopoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 68001-480-22

1 VIAL, SINGLE-DOSE in 1 CARTON (68001-480-22) > 5 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2020-12-14
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Irinotecan hydrochloide" or generic name "Irinotecan Hydrochloide"

NDCBrand NameGeneric Name
68001-480Irinotecan hydrochloideIrinotecan hydrochloide
68083-381Irinotecan hydrochloideIrinotecan hydrochloide
70700-169Irinotecan hydrochloideIrinotecan hydrochloide

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.